The Island nations of the Pacific have a very low cancer incidence rate. Many epidemiological studies have been undertaken to find the reason for this low cancer incidence rate including a study performed by STEINER LABORATORIES. The chart below published by STEINER LABORATORIES shows an essentially perfect correlation exists between the consumption of a local plant and a reduction in the cancer incidence rate (Chart 1). The active ingredient in this plant has been purified and concentrated to produce PREVASE. In the laboratory PREVASE has been found to reduce two prominent pathological molecules, Tumor necrosis factor alpha and COX-2. Tumor necrosis factor and COX-2 are known to be involved in the early stages of cancer development. For the references cited please contact us at staff@steinerlabs.com.*

*The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent any disease.

cancer/100k vs. consumption kg/yr. r -.98         cancer/100k vs. log consumption kg/yr. r -.99

Each Tablet Contains:

Active ingredients: 95 mg kavapyrones

Other ingredients: dicalcium phosphate, microcrystalline cellulose, gum acacia, magnesium sterate, silicon dioxide

Directions and Dosage:

It is well understood that it takes a very long time for cancer to develop. Therefore, any supplement designed to inhibit the production of pathologic cellular enzymes does not need to be taken continually. PREVASE only needs to be taken frequently enough to periodically inhibit the effects of the pathologic enzymes. Also, any biologically active supplement such as PREVASE should be taken with scheduled periods when the supplement is not taken to reduce the possibility of side effects and maintain efficacy.

Take two tablets of PREVASE after the evening meal for five days followed by two days without taking PREVASE.

After following this regimen for two months PREVASE should be stopped for one month before resuming PREVASE.

Everyone taking this supplement should be under the care of a health professional and following the advice of their health professional regarding cancer prevention. It is important to inform your health professional that you are taking this supplement. It is also advised that you bring this package to your health professional so they can advise you regarding any interaction with your medications or any other health concerns. PREVASE is not a treatment for cancer but a supplement designed to inhibit the production of molecules known to be involved in the initiation of cancer. If you or your health professional has any questions please contact us at staff@steinerlabs.com.

Key Benefits

• REDUCES TWO ENZYMES KNOWN TO INITIATE CANCER
• DOES NOT NEED TO BE TAKEN DAILY TO BE EFFECTIVE
• CAN BE USED IN CONJUNCTION WITH OTHER ANTICANCER MEDICATION